3 min read

UBC Announces Acquisition of Examoto, LLC

UBC expands its position as the leader in REMS with Examoto’s tech expertise.
UBC expands its position as the leader in REMS with Examoto's tech expertise.

With this acquisition, UBC provides the most comprehensive REMS services and innovative risk mitigation solutions for the biopharmaceutical industry

BLUE BELL, P.A., July 28, 2022 – UBC, a biopharmaceutical leader providing integrated clinical, safety, and commercialization services, today announced that it has acquired Examoto, LLC, a Risk Evaluation and Mitigation Strategy (REMS) company. Examoto is dedicated to the design, development, deployment, and streamlined operation of technologically driven REMS services in the pharmaceutical market. Transaction terms were not disclosed.

Patrick Lindsay, UBC’s President and CEO, said, “We are excited by the compelling opportunities this acquisition presents to expand the industry’s leading one-stop-shop for full-service REMS programs. The combination of Examoto’s technology-driven approach with UBC’s scientific, technological, and operational expertise will ensure the most efficient delivery of successful REMS programs to patients and clients.”

“Examoto’s technology and design innovations, in concert with UBC’s Project Management Office and related REMS services, creates a REMS powerhouse. We will collectively have the most comprehensive, proven capabilities for risk mitigation solutions for the pharma industry,” concluded Jason Leedy, Examoto’s Founder. “This strategic combination will encourage efficiency, quality, creativity, and synergy across the various REMS workflows and will provide sponsors with a single point of responsibility for their clinical programs.”

Natalie O’Donnell, Corporate Vice President, UBC Safety and Risk Management, added, “Today’s healthcare market increasingly demands evidence of drug safety and effectiveness to ensure sufficient validation. Our acquisition of Examoto helps cement UBC’s status as a preeminent leader in this category with a full-service REMS solution that leverages enhanced technologies and product innovations to help mitigate safety risk while optimizing the commercialization and delivery of products to market.”

About UBC

United BioSource LLC (UBC) is a leader in the biopharmaceutical market that provides integrated clinical, safety, and commercialization services. UBC combines renowned scientific research and operations experts with innovative technologies, allowing for the best patient and healthcare provider experience. Comprehensive, end-to-end services cover product and patient population characterization during development and market entry, as well as a focus on the patient experience, safety, and adherence. For additional information, visit www.ubc.com.

About Examoto, LLC

Examoto, LLC is a leader in FDA-mandated REMS compliance platforms addressing safer pharmaceutical outcomes. Built on decades of expertise, Examoto addresses the goals of maximizing the benefits and safe use of prescription drugs while reducing the burden to patients, healthcare providers, and the healthcare delivery system. Examoto accomplishes this through the design, development, deployment, and streamlined operation of technologically driven REMS services including web, mobile, data, voice, SMS, and chat for public digital environments. For more information, visit www.examoto.com.

MEDIA INQUIRIES

Amber Frasketi

UBC

Phone: 215.588.8423

Email: amber.frasketi@ubc.com

Other Recent Posts

Press
5 min read

UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation

This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.
Press
3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.
Press
1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.